Last $7.41 USD
Change Today +0.03 / 0.41%
Volume 233.3K
OSUR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen R. Lee Ph.D.

Former Chief Science Officer and Executive Vice President of Research and Development, OraSure Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

54$889,946
As of Fiscal Year 2013

Background*

Dr. Stephen R. Lee, also known as Steve, Ph.D. served as the Chief Science Officer and Executive Vice President of Research and Development at OraSure Technologies, Inc. from September 26, 2005 to February 28, 2014. Dr. Lee has more than 25 years of experience in the immunodiagnostic industry and joined OraSure from Ortho-Clinical Diagnostics, a Johnson & Johnson company. While at Ortho-Clinical Diagnostics, he served as Vice President of Assay Research & Development, ...

Read Full Background

Corporate Headquarters*

220 East First Street
Bethlehem, Pennsylvania 18015

United States

Phone: 610-882-1820
Fax: 610-882-1830

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1985
University of Cardiff
BS 1981
The University of Sheffield

Other Affiliations*

Annual Compensation*

Salary$377,535
Total Annual Compensation$377,535

Stock Options*

Restricted Stock Awards$139,463
All Other Compensation$4,000
Exercisable Options199,495
Exercisable Options Value$55,645
Unexercisable Options88,663
Unexercisable Options Value$1,043
Total Value of Options$56,687
Total Number of Options288,158

Total Compensation*

Total Annual Cash Compensation$541,355
Total Short Term Compensation$377,535
Other Long Term Compensation$143,463
Total Calculated Compensation$889,946
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSUR:US $7.41 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paul Averback M.D., DABPFounder, Chairman, Chief Executive Officer, President and Member of Communications Committee
Nymox Pharmaceutical Corporation
$290.0K
Ronan O’Caoimh Co-Founder, Chairman, Chief Executive Officer and Chairman of Compensation Committee
Trinity Biotech plc
$877.0K
John J. Sperzel III, B.Sc.Chief Executive Officer, President and Director
Chembio Diagnostics, Inc.
--
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$621.0K
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORASURE TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.